Terms: = Uterine cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
40 results:
1. Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and prognosis Evaluation of Cervical cancer.
Zhang M; Xin L; Cheng B; Yan B; Zhen J; Yang C; Ma L; Hou Q
Altern Ther Health Med; 2023 Nov; 29(8):788-792. PubMed ID: 37708549
[TBL] [Abstract] [Full Text] [Related]
2. The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma.
Di Dio C; Bogani G; Di Donato V; Cuccu I; Muzii L; Musacchio L; Scambia G; Lorusso D
Gynecol Oncol; 2023 Feb; 169():27-33. PubMed ID: 36493574
[TBL] [Abstract] [Full Text] [Related]
3. Advanced and recurrent endometrial cancer: State of the art and future perspectives.
Tronconi F; Nero C; Giudice E; Salutari V; Musacchio L; Ricci C; Carbone MV; Ghizzoni V; Perri MT; Camarda F; Gentile M; Berardi R; Scambia G; Lorusso D
Crit Rev Oncol Hematol; 2022 Dec; 180():103851. PubMed ID: 36257537
[TBL] [Abstract] [Full Text] [Related]
4. Atypical presentation of a rare gestational trophoblastic neoplasm: A case report.
Aamir FB; Raza Raja MH; Ahmad Zaidi SM; Noorali AA; Pervez MB; Fatimi SH
J Pak Med Assoc; 2022 Jun; 72(6):1260-1262. PubMed ID: 35751357
[TBL] [Abstract] [Full Text] [Related]
5. Clinico-pathological features associated with mismatch repair deficiency in endometrial undifferentiated/dedifferentiated carcinoma: A systematic review and meta-analysis.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Riccardi C; Mollo A; Zullo F; Insabato L
Gynecol Oncol; 2021 Feb; 160(2):579-585. PubMed ID: 33276986
[TBL] [Abstract] [Full Text] [Related]
6. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
7. TA-muc1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.
Heublein S; Friese K; Kost B; Marmé F; Kuhn C; Mahner S; Dannecker C; Mayr D; Jeschke U; Vattai A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1899-1907. PubMed ID: 30062487
[TBL] [Abstract] [Full Text] [Related]
8. Role of chemotherapy and thrombolysis in treatment of choriocarcinoma accompanied with pulmonary embolism: A case report with literature review.
Yang M; Peng L
Medicine (Baltimore); 2017 Sep; 96(36):e7866. PubMed ID: 28885339
[TBL] [Abstract] [Full Text] [Related]
9. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China.
He L; Li JD; Xiong Y; Huang X; Huang L; Lin JX; Zhou Y; Zheng M
Arch Gynecol Obstet; 2014 Feb; 289(2):383-91. PubMed ID: 23959089
[TBL] [Abstract] [Full Text] [Related]
11. [Glassy cell carcinoma of cervix: a clinicopathologic analysis of 5 cases].
Zhu HT; Li SX
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):523-7. PubMed ID: 22169640
[TBL] [Abstract] [Full Text] [Related]
12. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract] [Full Text] [Related]
13. Expression of mucin antigens (muc1 and muc16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
[TBL] [Abstract] [Full Text] [Related]
14. Placental site trophoblastic tumor (PSTT) with multiple metastases and extremely poor prognosis.
Ohmaru T; Yamakawa H; Netsu S; Nokubi M; Konno R
Int J Clin Oncol; 2009 Oct; 14(5):452-6. PubMed ID: 19856056
[TBL] [Abstract] [Full Text] [Related]
15. Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Behtash N; Behnamfar F; Hamedi B; Ramezanzadeh F
Arch Gynecol Obstet; 2009 Apr; 279(4):579-81. PubMed ID: 18726607
[TBL] [Abstract] [Full Text] [Related]
16. [Placental site trophoblastic tumor: case report and review of literature].
Kunz J; Bannwart F
Praxis (Bern 1994); 2008 Apr; 97(7):387-94. PubMed ID: 18548819
[TBL] [Abstract] [Full Text] [Related]
17. The mucin expression profile of endometrial carcinoma and correlation with clinical-pathologic parameters.
Morrison C; Merati K; Marsh WL; De Lott L; Cohn DE; Young G; Frankel WL
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):426-31. PubMed ID: 18091386
[TBL] [Abstract] [Full Text] [Related]
18. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with muc1 and muc16 (CA125).
Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
[TBL] [Abstract] [Full Text] [Related]
19. Intraplacental choriocarcinoma metastasizing to the maternal lung.
Landau D; Maor E; Maymon E; Rabinovich A; Piura B
Eur J Gynaecol Oncol; 2006; 27(1):29-32. PubMed ID: 16550964
[TBL] [Abstract] [Full Text] [Related]
20. Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma.
Arai T; Watanabe J; Kawaguchi M; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
Int J Gynecol Cancer; 2006; 16(1):391-5. PubMed ID: 16445664
[TBL] [Abstract] [Full Text] [Related]
[Next]
